Sergio Abanades

2.0k total citations
26 papers, 1.4k citations indexed

About

Sergio Abanades is a scholar working on Toxicology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sergio Abanades has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Toxicology, 10 papers in Pharmacology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sergio Abanades's work include Forensic Toxicology and Drug Analysis (10 papers), Cannabis and Cannabinoid Research (9 papers) and Psychedelics and Drug Studies (7 papers). Sergio Abanades is often cited by papers focused on Forensic Toxicology and Drug Analysis (10 papers), Cannabis and Cannabinoid Research (9 papers) and Psychedelics and Drug Studies (7 papers). Sergio Abanades collaborates with scholars based in Spain, Italy and United Kingdom. Sergio Abanades's co-authors include Magı́ Farré, Rafael de la Torre, Mireia Segura, Pere N. Roset, Jordi Segura, Jordi Camı́, Roberta Pacifici, Simona Pichini, Klaus Langohr and Manuela Pellegrini and has published in prestigious journals such as NeuroImage, Annals of the New York Academy of Sciences and Journal of Nutrition.

In The Last Decade

Sergio Abanades

26 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sergio Abanades Spain 17 553 466 444 421 173 26 1.4k
Clara Pérez‐Mañá Spain 25 543 1.0× 516 1.1× 425 1.0× 407 1.0× 205 1.2× 100 2.0k
Pere N. Roset Spain 22 1.1k 2.1× 730 1.6× 642 1.4× 916 2.2× 218 1.3× 29 2.1k
Nieves Pizarro Spain 21 606 1.1× 336 0.7× 340 0.8× 462 1.1× 51 0.3× 37 1.2k
Mitona Pujadas Spain 31 809 1.5× 439 0.9× 429 1.0× 569 1.4× 575 3.3× 50 2.5k
Esther Papaseit Spain 23 716 1.3× 528 1.1× 355 0.8× 452 1.1× 37 0.2× 97 1.7k
Arno Hazekamp Netherlands 27 339 0.6× 1.9k 4.1× 322 0.7× 291 0.7× 57 0.3× 41 2.5k
E. J. M. Pennings Netherlands 18 349 0.6× 275 0.6× 262 0.6× 213 0.5× 54 0.3× 41 1.3k
Esa Meririnne Finland 14 133 0.2× 171 0.4× 392 0.9× 123 0.3× 29 0.2× 23 1.2k
Karl‐Artur Kovar Germany 21 460 0.8× 236 0.5× 461 1.0× 482 1.1× 166 1.0× 76 1.4k
W. Brooks Gentry United States 25 254 0.5× 369 0.8× 502 1.1× 59 0.1× 34 0.2× 51 2.1k

Countries citing papers authored by Sergio Abanades

Since Specialization
Citations

This map shows the geographic impact of Sergio Abanades's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Abanades with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Abanades more than expected).

Fields of papers citing papers by Sergio Abanades

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Abanades. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Abanades. The network helps show where Sergio Abanades may publish in the future.

Co-authorship network of co-authors of Sergio Abanades

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Abanades. A scholar is included among the top collaborators of Sergio Abanades based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Abanades. Sergio Abanades is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
López-Carrasco, Amparo, Fernando Fariñas, Antonio J. Villatoro, et al.. (2021). Immunometabolism Modulation in Therapy. Biomedicines. 9(7). 798–798. 9 indexed citations
2.
López-Carrasco, Amparo, et al.. (2021). Metabolic Classification and Intervention Opportunities for Tumor Energy Dysfunction. Metabolites. 11(5). 264–264. 10 indexed citations
3.
Pérez, E., Sergio Abanades, Xavier Vidal, et al.. (2010). Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy‐induced nausea and vomiting. British Journal of Clinical Pharmacology. 70(5). 656–663. 105 indexed citations
4.
Pichini, Simona, Magı́ Farré, Sergio Abanades, et al.. (2010). CLINICAL STUDY: FULL ARTICLE: Immunomodulating properties of gamma‐hydroxybutyrate (GHB), flunitrazepam and ethanol in ‘club drugs’ users. Addiction Biology. 15(3). 336–345. 8 indexed citations
5.
Rodríguez, José, Elvira Munteis, Mar Carreño, et al.. (2008). Cannabis use in Spanish patients with multiple sclerosis: Fulfilment of patients' expectations?. Journal of the Neurological Sciences. 273(1-2). 103–107. 18 indexed citations
6.
Farré, Magí, et al.. (2008). Study of paracetamol 1g oral solution bioavailability. Methods and Findings in Experimental and Clinical Pharmacology. 30(1). 37–37. 8 indexed citations
7.
Márquez, Lucía, Sergio Abanades, & Montserrat Andreu. (2008). Sistema endocannabinoide e inflamación intestinal. Medicina Clínica. 131(13). 513–517. 2 indexed citations
8.
Farré, Magı́, Amin Rostami‐Hodjegan, Jiansong Yang, et al.. (2008). The Consequences of 3,4-Methylenedioxymethamphetamine Induced CYP2D6 Inhibition in Humans. Journal of Clinical Psychopharmacology. 28(5). 523–529. 47 indexed citations
9.
Abanades, Sergio, Magı́ Farré, Mireia Segura, et al.. (2007). Disposition of Gamma-Hydroxybutyric Acid in Conventional and Nonconventional Biologic Fluids After Single Drug Administration: Issues in Methodology and Drug Monitoring. Therapeutic Drug Monitoring. 29(1). 64–70. 55 indexed citations
10.
Farré, Magı́, Sergio Abanades, Pere N. Roset, et al.. (2007). Pharmacological Interaction between 3,4-Methylenedioxymethamphetamine (Ecstasy) and Paroxetine: Pharmacological Effects and Pharmacokinetics. Journal of Pharmacology and Experimental Therapeutics. 323(3). 954–962. 82 indexed citations
11.
12.
Pacifici, Roberta, Piergiorgio Zuccaro, Magı́ Farré, et al.. (2007). Combined immunomodulating properties of 3,4‐methylenedioxymethamphetamine (MDMA) and cannabis in humans. Addiction. 102(6). 931–936. 29 indexed citations
13.
Abanades, Sergio, Magı́ Farré, Marta Torrens, et al.. (2007). Relative Abuse Liability of γ-Hydroxybutyric Acid, Flunitrazepam, and Ethanol in Club Drug Users. Journal of Clinical Psychopharmacology. 27(6). 625–638. 51 indexed citations
14.
Abanades, Sergio, Magı́ Farré, Mireia Segura, et al.. (2006). γ‐Hydroxybutyrate (GHB) in Humans. Annals of the New York Academy of Sciences. 1074(1). 559–576. 103 indexed citations
15.
Farré, Magı́, et al.. (2005). Estudio de la biodisponibilidad en magnitud y en velocidad de comprimidos de ibuprofeno. Reumatología Clínica. 1(3). 155–160. 1 indexed citations
16.
Pichini, Simona, Sergio Abanades, Magı́ Farré, et al.. (2005). Quantification of the plant‐derived hallucinogen Salvinorin A in conventional and non‐conventional biological fluids by gas chromatography/mass spectrometry after Salvia divinorum smoking. Rapid Communications in Mass Spectrometry. 19(12). 1649–1656. 44 indexed citations
17.
Aznar, Esteban, et al.. (2005). Resistencia en "Mycobacterium tuberculosis" durante un periodo de cuatro años en un hospital de Madrid. 5 indexed citations
18.
Abanades, Sergio, Ana M. Peiró, & Magı́ Farré. (2004). Club drugs: los viejos fármacos son las nuevas drogas de la fiesta. Medicina Clínica. 123(8). 305–311. 18 indexed citations
19.
Weinbrenner, Tanja, Montserrat Fitó, Rafael de la Torre, et al.. (2004). Olive Oils High in Phenolic Compounds Modulate Oxidative/Antioxidative Status in Men. Journal of Nutrition. 134(9). 2314–2321. 210 indexed citations
20.
Torre, Rafael de la, Magı́ Farré, Pere N. Roset, et al.. (2004). Human Pharmacology of MDMA. Therapeutic Drug Monitoring. 26(2). 137–144. 317 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clara Pérez‐Mañá Breakdown of academic impact, for papers by Pere N. Roset Breakdown of academic impact, for papers by Nieves Pizarro Breakdown of academic impact, for papers by Mitona Pujadas Breakdown of academic impact, for papers by Esther Papaseit Breakdown of academic impact, for papers by Arno Hazekamp Breakdown of academic impact, for papers by E. J. M. Pennings Breakdown of academic impact, for papers by Esa Meririnne Breakdown of academic impact, for papers by Karl‐Artur Kovar Breakdown of academic impact, for papers by W. Brooks Gentry
Rankless by CCL
2026